Immuron achieves record half yearly Travelan® sales
16 janv. 2024 06h00 HE
|
Immuron Limited
Highlights: Record half yearly Travelan® sales of $2,334,969Total sales of A$2,355,580 in H1, FY24 $1,771,932 increase on H1, FY23 sales51% higher than pre-pandemic period H1, FY20 sales ...
Immuron achieves record quarterly Travelan® sales
11 oct. 2023 06h00 HE
|
Immuron Limited
Highlights: Record quarterly Travelan® sales of $1,550,240Total sales of A$1,565,767 in Q1, FY24 $1,508,933 increase on Q1, FY23 sales130% higher than pre-pandemic period Q1, FY20 sales ...
Immuron to present at the Military Health System Research Symposium
14 août 2023 06h00 HE
|
Immuron Limited
MELBOURNE, Australia, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce that it...
Immuron Announces First Patients Enrolled in Travelan® Clinical Study
25 juil. 2023 06h00 HE
|
Immuron Limited
Highlights: First cohort of 30 healthy volunteers enrolled in the Travelan® Clinical Trial Clinical Trial to examine a dosing regimen for Travelan® more suited to the US military has commenced...
Immuron Business Update: Letter to Shareholders
22 juin 2023 06h00 HE
|
Immuron Limited
Highlights: Immuron Board approves IMM-529 cGMP manufacturing and to proceed with FDA pre-IND submissionRecruitment and screening update for Travelan® Controlled Human Infection Model (CHIM)...
Immuron Initiates Recruitment of Travelan® Clinical Study
30 mai 2023 06h00 HE
|
Immuron Limited
Highlights: Immuron receives approval from U.S. Army Medical Research and Development CommandRecruitment and screening of healthy volunteers for Travelan® Controlled Human Infection Model (CHIM)...
US Department of Defense Uniformed Services University Clinical Evaluation of Travelan™ Achieves 150 Recruitment Milestone
18 janv. 2023 05h00 HE
|
Immuron Limited
Highlights: First participants enrolled in USU Travelan Clinical Trial Field Study157 participants successfully randomized into the Clinical StudyPlans in place to enrol in 1302 healthy volunteers in...
Immuron Submits IND Application To FDA for Travelan
05 déc. 2022 06h00 HE
|
Immuron Limited
Highlights: Investigational New Drug (IND) application submitted to the U.S. Food and Drug administration (FDA)Plans in place to initiate a Human clinical trial in 60 healthy volunteers in the...
Immuron Executes Travelan Clinical Trial Agreement with US-based Pharmaron
04 oct. 2022 06h00 HE
|
Immuron Limited
Highlights: Clinical Trial Master Service Agreement with US-based Pharmaron ExecutedInvestigational New Drug (IND) application to be submitted to the U.S. Food and Drug administration (FDA)Plans in...
US Department of Defense Uniformed Services University Clinical Evaluation of Travelan™
09 mai 2022 06h00 HE
|
Immuron Limited
UPDATE Key Points Manufacture Completed of investigational medical products to be clinically evaluated by the Uniformed Services University (USU). The clinical program aims to determine the...